相关实验视频

Updated: Jun 29, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

基于生物信息学分析和机器学习的免疫相关生物标志物的查与肌痛性肌痛症和扩张性心肌病相关

Guiting Zhou¹, Shushu Wang¹, Liwen Lin¹

¹The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.

|April 4, 2024

概括

这项研究确定了关键的基因和免疫路径,涉及肌痛性肌痛症 (MG) 和扩张性心肌病 (DCM) 的共同发生. 它开发了一个使用MID1IP1和PIK3IP1的诊断名录,以改善MG相关的DCM检测.

科学领域:

心血管研究研究心血管研究
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

骨髓灰质炎 (MG) 和扩张性心肌病 (DCM) 可以同时发生,这表明共享的潜在机制.
研究MG和DCM之间的遗传和分子联系对于理解它们的病变产生至关重要.

研究的目的:

识别与肌痛性肌痛症 (MG) 相关的基因及其在扩张性心肌病 (DCM) 中的潜在作用.
发现用于诊断同时发生的MG和DCM的生物标志物.

主要方法:

对DCM和MG的GEO数据集进行差异基因表达分析和权重基因同表达网络分析 (WGCNA).
蛋白质与蛋白质相互作用 (PPI),基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 路径分析.
机器学习用于生物标记物识别,诊断名录开发和使用外部数据集进行验证.

主要成果:

确定了DCM和MG共同的11个差异表达基因,主要与炎症和免疫调节有关.
机器学习确定了中线1相互作用蛋白1 (MID1IP1) 和PI3K相互作用蛋白1 (PIK3IP1) 作为MG相关的DCM的潜在诊断生物标志物.
使用MID1IP1和PIK3IP1开发了具有最佳预测性能的诊断名录,在两种条件下揭示了免疫失调.

结论:

在MG相关的DCM中阐明了炎症和免疫路径.
使用MID1IP1和PIK3IP1.1.开发了一种用于MG相关的DCM的新型诊断名谱.
为未来的诊断和治疗策略提供了洞察力,用于同时发生的MG和DCM.

关键词:

诊断值是一个诊断值.扩展性心肌病变异症扩展性心肌病变异症免疫细胞的透.机器学习算法机器学习算法骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.

更多相关视频

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...